Outcomes of early versus delayed laparoscopic cholecystectomy for acute cholecystitis performed at a single institution.


Journal

Asian journal of endoscopic surgery
ISSN: 1758-5910
Titre abrégé: Asian J Endosc Surg
Pays: Japan
ID NLM: 101506753

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 15 01 2018
revised: 22 02 2018
accepted: 05 03 2018
pubmed: 4 4 2018
medline: 5 6 2019
entrez: 4 4 2018
Statut: ppublish

Résumé

Debate continues regarding the clinical outcomes of early laparoscopic cholecystectomy (ELC) versus delayed laparoscopic cholecystectomy (DLC) for acute cholecystitis (AC). The aim of this retrospective study was to compare clinical outcomes of ELC and DLC. This study consisted of 465 patients who had undergone laparoscopic cholecystectomy for AC between January 2000 and February 2017. Patients were divided between an ELC group (patients who underwent laparoscopic cholecystectomy within 6 days of symptom onset, n = 288) and a DLC group (patients who underwent laparoscopic cholecystectomy at least 7 days from symptom onset, n = 177), and clinical outcomes were compared. Operation time (105 vs 124 min), length of postoperative hospital stay (4 vs 4 days), conversion rate (1.3% vs 10.7%), bile leak (0.3% vs 3.3%), residual calculus (2.4% vs 6.7%), and readmission (1.0% vs 6.7%) were significantly better in the ELC group. A history of upper abdominal surgery, grade II or grade III AC, preoperative percutaneous transhepatic gallbladder drainage, and time between symptom onset and surgery of more than 7 days were independent risk factors for conversion. ELC for AC yields more favorable clinical outcomes than DLC.

Identifiants

pubmed: 29611896
doi: 10.1111/ases.12487
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

74-80

Informations de copyright

© 2018 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and John Wiley & Sons Australia, Ltd.

Auteurs

Atsushi Kohga (A)

Division of Surgery, Fujinomiya City General Hospital, Fujinomiya, Japan.

Kenji Suzuki (K)

Division of Surgery, Fujinomiya City General Hospital, Fujinomiya, Japan.

Takuya Okumura (T)

Division of Surgery, Fujinomiya City General Hospital, Fujinomiya, Japan.

Kimihiro Yamashita (K)

Division of Surgery, Fujinomiya City General Hospital, Fujinomiya, Japan.

Jun Isogaki (J)

Division of Surgery, Fujinomiya City General Hospital, Fujinomiya, Japan.

Akihiro Kawabe (A)

Division of Surgery, Fujinomiya City General Hospital, Fujinomiya, Japan.

Taizo Kimura (T)

Division of Surgery, Fujinomiya City General Hospital, Fujinomiya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH